Nasr,Samya M.D. [Ann Arbor / United States of America]

Nasr,Samya M.D. [Ann Arbor / United States of America] located in ANN ARBOR MICHIGAN, United States of America had its last known inspection on 01 Sep 2011. There are 2 known inspections on record.

Site Details

Industries:
Human Drugs
Tags:
Human Drugs, Clinical Investigator
Last Inspection Date:
01 Sep 2011
FEI:
3000207178
Redica ID:

Nasr,Samya M.D. [Ann Arbor / United States of America]'s Most Recent Documents

Publish Date Document Type Title
September, 2011 FDA 483 Nasr,Samya M.D. - Form 483, 2011-09-01

Experience Redica Systems’ NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Site Profile Icon

Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more